Visual Field Assessment With Subjects Who Receive Either Lyrica Or Sugar Pills

Prospective Randomized 12-Week Controlled Study Of Visual Field Change In Subjects With Partial Seizures Receiving Pregabalin Or Placebo - Not applicable

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2009/091/000872

Enrollment

284

Registered

2009-12-01

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Epilepsies, Partial

Interventions

Intervention1: Lyrica (pregabalin): 150 mg twice a day, oral administration Control Intervention1: Placebo: Placebo Comparator placebo comparator Intervention Drug: placebo : twice a day, oral admini

Eligibility

Inclusion criteria

Inclusion criteria: a. Ages Eligible for Study: 18 Years to 65 Years b. Genders Eligible for Study: Both c. Accepts Healthy Volunteers: No 1.Epilepsy partial seizure subjects.

Exclusion criteria

Exclusion criteria: Pre-existing eye diseases.

Design outcomes

Primary

Measure	Time frame
Visual field changes, if there is any, while comparing before and after the study drug or placebo consumption will be assessed.Timepoint: 3 months	—

Secondary

Measure	Time frame
Visual acuity will be assessed at the beginning and end of the study as well.Timepoint: 3 months	—

Countries

Bulgaria, Czech Republic, Hungary, India, Mexico, Poland, Republic of Korea, Thailand, United States of America

Contacts

Public ContactDr Seema Pai

Pfizer Limited

Karan.Thakkar@Pfizer.com91-7045788858

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026